CDF-Capital is a private equity firm invests in growth and early-stage companies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
CDF-Capital is a private equity firm invests in growth and early-stage companies and its business covers 3+1 investment, including equity investment (start-up investment, M&a;A investment, industrial investment) and incubation investment (Chuangzhan Incubator). Since its establishment, it has received funding and recognition from the State Ministry (Ministry of Finance, Ministry of Science and Technology), government guidance funds, parent funds, banks, and insurance companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2015 | Qichacha | Angel Round | 1.6M |
2/2015 | vipc.cn | Angel Round | 963.8k |
7/2018 | Kehigh Academy | Series A | - |
8/2016 | Touzhijia | Series A | 12M |
6/2008 | Temobi.com | Series A | 2.2M |
11/2010 | Rising | Series C | - |
3/2020 | Wicue | Series A | 2.9M |
8/2015 | Kaisan Yun Jiang Wang | Series A | 4.7M |
4/2015 | Kaisan Yun Jiang Wang | Seed Round | 1.6M |
8/2015 | vipc.cn | Series A | 0 |
6/2022 | Ada | Series B | - |
6/2009 | Navidog | Series A | - |
12/2021 | Meikai Information Technology | Series A | - |
4/2015 | 9kus | Angel Round | 1.3M |
7/2017 | vipc.cn | Series B | 8.1M |
6/2014 | Taiyizhishang | Series B | 3.2M |
1/2016 | Pok9tvip | Series A | - |
1/2012 | Yikuaiqu | Seed Round | 800k |
11/2008 | ChinaNetCenter | Series B | 5.8M |
3/2017 | Baiqishi | Series A | 1.5M |
6/2019 | Rinfon | Series B | 14.6M |
8/2016 | Huize | Series B | 15M |
9/2009 | ChinaNetCenter | Series D | 4.4M |
12/2018 | Dowsure | Series A | 1.5M |
2/2020 | MCLogic | Series A | - |
3/2017 | Channelsoft (Beijing) Technology | Series B | - |
1/2016 | Sanshi Technology | Series B | - |
1/2022 | Cloudbreak Therapeutics | Series C | 0 |
7/2010 | Temobi.com | Series C | 4.4M |
12/2011 | YL1001.com | Series A | 1.7M |
7/2015 | Haimawan | Series B | 16.2M |
12/2021 | ImmuneOnco Biopharma | Venture Round | 100M |
1/2022 | ImmuneOnco Biopharma | Series C | 100M |
9/2014 | Gaosouyi | Angel Round | 4.9M |
12/2011 | Longwen Education | Series A | 71M |
8/2022 | Chuangxin Microelectronics | Series B | 29.1M |
12/2016 | Yingcan Technology | Angel Round | 431.6k |
12/2013 | Wangdaizhijia | Series A | 1.6M |
3/2010 | Maslong | Series A | 1.5M |
8/2014 | XGIMI | Series A | 16M |
11/2010 | Teamtop | Series A | 746.6k |
12/2015 | Seastars | Series C | 4.7M |
12/2011 | Job1001 | Venture Round | 642.4k |
3/2022 | Mapleson | Series A | 15.7M |
11/2019 | Bigfish Bio-tech | Series A | - |
9/2017 | Yilian Keji | Angel Round | 460.1k |
10/2017 | QieGaoWangzi | Series B | 3M |
12/2016 | ESPIRIT | Series B | 2.9M |
9/2010 | Navidog | Series B | - |
1/2014 | Zhizhangyi | Angel Round | 1.6M |
8/2014 | 1ismore | Series A | - |
5/2013 | Anbiping | Series A | 1.6M |
3/2022 | Tongluyun | Series A | 1.6M |
9/2015 | Shinemo | Series A | - |
10/2014 | cnmobi | Series A | - |
1/2012 | Landetao.com | Angel Round | 475.9k |
9/2019 | JingxunSoft | Series B | - |
6/2011 | Temobi.com | Series E | 7.7M |
12/2015 | ANTVR | Series B | 46M |
6/2022 | Ada | Series B | - |
3/2022 | Tongluyun | Series A | 0 |
3/2022 | Mapleson | Series A | 0 |
1/2022 | Cloudbreak Therapeutics | Series C | 0 |
1/2022 | ImmuneOnco Biopharma | Series C | 0 |
12/2021 | Meikai Information Technology | Series A | - |
3/2020 | Wicue | Series A | 0 |
2/2020 | MCLogic | Series A | - |
11/2019 | Bigfish Bio-tech | Series A | - |
9/2019 | JingxunSoft | Series B | - |
Name | Price |
---|
Name | Size | Announced Date |
---|